Louisiana 2021 Regular Session

Louisiana House Bill HR107

Introduced
5/19/21  
Introduced
5/19/21  
Refer
5/20/21  
Report Pass
5/25/21  
Passed
6/1/21  

Caption

Requests the La. Department of Health to ensure that Medicaid managed care organizations cover and pay for certain respiratory panels

Impact

If adopted, HR107 would have a significant impact on state healthcare policies by mandating that Medicaid managed care organizations do not impose unnecessary restrictions on coverage for respiratory panels. This would align with the growing need for comprehensive testing options to address the ongoing challenges posed by the COVID-19 pandemic and other respiratory diseases. The resolution underscores the importance of timely and effective diagnosis and treatment in limiting the spread of infections, which could lead to improvements in overall public health in Louisiana.

Summary

House Resolution 107 (HR107) requests the Louisiana Department of Health to ensure that Medicaid managed care organizations provide coverage and payment for certain respiratory panels. The resolution emphasizes the need for these panels, particularly in the context of the COVID-19 pandemic, highlighting their role in detecting and treating respiratory infections. The use of these tests has increased as they allow for the identification of various respiratory illnesses, thus improving patient outcomes and ultimately aiding in public health efforts.

Sentiment

The general sentiment surrounding HR107 appears to be positive, with strong support from legislators who recognize the value of expanding access to critical testing resources. The unanimous vote of 97-0 in the House further indicates broad bipartisan support for the bill. However, there may be underlying concerns about the operational implications for Medicaid managed care organizations and how they will implement these changes in coverage.

Contention

Despite the strong support, there may be potential contention regarding the logistics of expanding coverage for respiratory panels. Managed care organizations might raise concerns about reimbursement rates and the potential financial impact of covering additional tests. Though the resolution is aimed at enhancing healthcare access, there are practical challenges in ensuring that all stakeholders are aligned with the new requirements, particularly in terms of payment structures and provider compliance.

Companion Bills

No companion bills found.

Similar Bills

CA SB1003

Respiratory therapy.

CA SB1436

Respiratory therapy.

MI HB5794

Health occupations: respiratory therapists; licensure for respiratory therapists; modify. Amends secs. 16204, 16344, 18701, 18703, 18707 & 18709 of 1978 PA 368 (MCL 333.16204 et seq.) & adds secs. 18710 & 18712.

TX SB294

Relating to the use of epinephrine auto-injectors and medication designated for treatment of respiratory distress on public and private school campuses.

TX HB920

Relating to the use of medication designated for treatment of respiratory distress on public and private school campuses.

DE SB94

An Act To Amend Title 24 Of The Delaware Code Relating To Respiratory Care Practitioners.

HI HB664

Relating To Health.

HI SB599

Relating To Health.